TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 184 filers reported holding TG THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.79 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $206,994 | -68.6% | 24,760 | -6.7% | 0.00% | -66.7% |
| Q2 2023 | $659,303 | +69.2% | 26,542 | +2.4% | 0.00% | +50.0% |
| Q1 2023 | $389,732 | +42.9% | 25,913 | +12.4% | 0.00% | +100.0% |
| Q4 2022 | $272,788 | +102.1% | 23,059 | +0.8% | 0.00% | 0.0% |
| Q3 2022 | $135,000 | +13400.0% | 22,865 | +8528.3% | 0.00% | – |
| Q2 2022 | $1,000 | -75.0% | 265 | -35.7% | 0.00% | – |
| Q1 2022 | $4,000 | +100.0% | 412 | +312.0% | 0.00% | – |
| Q4 2021 | $2,000 | -50.0% | 100 | -9.9% | 0.00% | – |
| Q3 2021 | $4,000 | -20.0% | 111 | -6.7% | 0.00% | – |
| Q2 2021 | $5,000 | -16.7% | 119 | -4.8% | 0.00% | – |
| Q1 2021 | $6,000 | -87.0% | 125 | -85.9% | 0.00% | -100.0% |
| Q4 2020 | $46,000 | +84.0% | 885 | -5.3% | 0.00% | – |
| Q3 2020 | $25,000 | +66.7% | 935 | +27.2% | 0.00% | – |
| Q2 2020 | $15,000 | +400.0% | 735 | +22.5% | 0.00% | – |
| Q3 2019 | $3,000 | -40.0% | 600 | 0.0% | 0.00% | – |
| Q2 2019 | $5,000 | 0.0% | 600 | 0.0% | 0.00% | – |
| Q1 2019 | $5,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |